z-logo
open-access-imgOpen Access
Dapsone induced hemolysis in a patient with Hansen’s disease and G6PD deficiency: A preventable peril
Author(s) -
Ghorui Arnab Kumar,
Patra Pratap Kumar
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5700
Subject(s) - dapsone , medicine , hemolysis , leprosy , anemia , hemolytic anemia , pediatrics , dermatology , immunology
Although under‐reported, hemolytic anemia is common with dapsone‐containing regimen in leprosy. It is prudent to screen for underlying G6PD deficiency in boys before administering dapsone to prevent potentially life‐threatening episode of intravascular hemolysis in children with leprosy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here